Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease

Alzheimers Res Ther. 2024 Jul 10;16(1):159. doi: 10.1186/s13195-024-01507-7.
No abstract available

Publication types

  • Published Erratum